(Q30227484)

English

Vaccines for hantaviruses

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 June 2017

1 reference

Europe PubMed Central

Vaccines for hantaviruses (English)

1 reference

Europe PubMed Central

11 June 2017

1 reference

based on heuristic

inferred from title

Connie S Schmaljohn

1

object named as

Connie Schmaljohn

1 reference

Europe PubMed Central

11 June 2017

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

11 June 2017

1 reference

Europe PubMed Central

11 June 2017

27 Suppl 4

1 reference

Europe PubMed Central

11 June 2017

D61-4

1 reference

Europe PubMed Central

11 June 2017

Hantaviruses: history and overview

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

based on heuristic

inferred from DOI database lookup

Korean hemorrhagic fever: propagation of the etiologic agent in a cell line of human origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Distinction between Bunyaviridae genera by surface structure and comparison with Hantaan virus using negative stain electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Nephropathia epidemica in Finland: a retrospective study of 126 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Genetic susceptibility to haemorrhagic fever with renal syndrome caused by Hantaan virus in Chinese Han population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Monoclonal antibodies specific for Hantaan virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Partial characterization of Prospect Hill virus isolated from meadow voles in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

An outbreak of hantavirus pulmonary syndrome, Chile, 1997

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Cardiopulmonary manifestations of hantavirus pulmonary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Hantavirus infections in the United States: diagnosis and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Long-lived memory T lymphocyte responses after hantavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

A macaque model for hantavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Pathology of Puumala hantavirus infection in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

A lethal disease model for hantavirus pulmonary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Vaccines against hantaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Vaccines against hantaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Recent approaches in hantavirus vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Review of an inactivated vaccine against hantaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Protective effectiveness of hantavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

Nucleotide and deduced amino acid sequences of the M and S genome segments of two Puumala virus isolates from Russia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.096

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.07.096

1 reference

Europe PubMed Central

11 June 2017

1 reference

Europe PubMed Central

11 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30227484&oldid=1975548695"